BE2015C011I2 - - Google Patents

Download PDF

Info

Publication number
BE2015C011I2
BE2015C011I2 BE2015C011C BE2015C011C BE2015C011I2 BE 2015C011 I2 BE2015C011 I2 BE 2015C011I2 BE 2015C011 C BE2015C011 C BE 2015C011C BE 2015C011 C BE2015C011 C BE 2015C011C BE 2015C011 I2 BE2015C011 I2 BE 2015C011I2
Authority
BE
Belgium
Application number
BE2015C011C
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Publication of BE2015C011I2 publication Critical patent/BE2015C011I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE2015C011C 2004-06-24 2015-01-27 BE2015C011I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/874,532 US7854943B2 (en) 2004-06-24 2004-06-24 Phospholipid gel compositions for drug delivery and methods of treating conditions using same

Publications (1)

Publication Number Publication Date
BE2015C011I2 true BE2015C011I2 (fr) 2024-10-08

Family

ID=35506068

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2015C011C BE2015C011I2 (fr) 2004-06-24 2015-01-27

Country Status (4)

Country Link
US (1) US7854943B2 (fr)
CN (1) CN101014323B (fr)
BE (1) BE2015C011I2 (fr)
HU (1) HUS1500004I1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US8017159B2 (en) * 2005-11-16 2011-09-13 Idexx Laboratories, Inc. Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same
US9115358B2 (en) 2006-08-11 2015-08-25 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
WO2009046314A2 (fr) * 2007-10-04 2009-04-09 President And Fellows Of Harvard College Analogues de la moénomycine, procédés de synthèse et utilisations de ceux-ci
WO2010033726A2 (fr) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Composition pour la délivrance de médicament(s) comprenant un gélateur s'auto-assemblant
US20130280334A1 (en) 2010-09-24 2013-10-24 Massachusetts Institute Of Technology Nanostructured Gels Capable of Controlled Release of Encapsulated Agents
WO2013152279A1 (fr) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Procédés chimio-enzymatiques pour synthétiser des analogues de la moénomycine
US10106833B2 (en) 2012-04-06 2018-10-23 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
WO2013152277A2 (fr) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Analogues de la moénomycine, procédés de synthèse, et leurs utilisations
GB201511058D0 (en) * 2015-06-23 2015-08-05 Lamellar Biomedical Ltd Compositions and methods for using lamellar bodies for therapeutic purposes
CN109310775B (zh) 2016-05-06 2022-11-18 布里格姆及妇女医院股份有限公司 用于向软骨中受控递送被囊封的药剂的二元自组装凝胶
WO2018144991A1 (fr) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Gels auto-assemblés formés avec des médicaments anti-rétroviraux, leurs promédicaments et leurs utilisations pharmaceutiques
WO2018208822A1 (fr) * 2017-05-08 2018-11-15 Alivio Therapeutics, Inc. Formulation de gels nanostructurés pour une charge et une adhérence d'agent augmentées
EP3863602A1 (fr) 2018-10-11 2021-08-18 Alivio Therapeutics, Inc. Formulations d'hydrogel non injectables permettant une libération intelligente
JP7679396B2 (ja) * 2020-03-09 2025-05-19 アイデックス ラボラトリーズ インコーポレイテッド 液体サンプルの干渉成分を化学試薬検査スライドへの適用前に除去するための方法
WO2021221066A1 (fr) * 2020-04-28 2021-11-04 株式会社レオロジー機能食品研究所 Composition améliorant la fonction immunitaire

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909466A (en) * 1956-05-29 1959-10-20 Pfizer & Co C Stable solutions of oxytetracycline salts
US4025620A (en) * 1975-10-22 1977-05-24 Leo Pharmaceutical Products Ltd., A/S Treatment of canine otitis and composition therefor
NZ184548A (en) * 1976-07-06 1981-10-19 Bayer A Antimycotic compositions comprising imidazol-1-yl-(4-phenoxyphenyl)-(pyrid-2-yl)-phenylmethane
IE53610B1 (en) 1981-12-14 1988-12-21 Merck & Co Inc Waterless thixotropic composition
JPS6087215A (ja) 1983-10-19 1985-05-16 Mitsui Toatsu Chem Inc 外用薬用基材
FR2570602B1 (fr) * 1984-09-21 1986-11-28 Cird Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4837008A (en) * 1985-04-09 1989-06-06 Peroxydent Group Periodontal composition and method
US4843096A (en) * 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
US4847267A (en) * 1986-03-17 1989-07-11 Charles Of The Ritz Group Ltd. Skin treatment composition and method
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US4814173A (en) * 1987-09-08 1989-03-21 Warner-Lambert Company Silicone elastomer transdermal matrix system
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
WO1992008449A1 (fr) * 1990-11-09 1992-05-29 Teikoku Seiyaku Kabushiki Kaisha Platre contenant du procaterol
HU223343B1 (hu) 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5656355A (en) * 1992-03-12 1997-08-12 Kimberly-Clark Corporation Multilayer elastic metallized material
ZA934893B (en) * 1992-07-20 1995-01-09 Colgate Palmolive Co Gelled organic liquids
US5631004A (en) * 1993-09-30 1997-05-20 Alcon Laboratories, Inc. Use of sustained release antibiotic compositions in ophthalmic surgical procedures
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6165987A (en) * 1996-07-30 2000-12-26 Harvey; Colin Manson Anthelmintic formulations
ES2158611T3 (es) * 1996-12-20 2001-09-01 Alza Corp Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion.
US6630168B1 (en) 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
US6018033A (en) * 1997-05-13 2000-01-25 Purdue Research Foundation Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same
AU1827799A (en) * 1997-12-15 1999-07-05 Axia Therapeutics, Inc. Oral delivery formulation
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6436455B2 (en) * 1998-06-15 2002-08-20 General Mills, Inc. Multi-colored aerated confectionery products
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
GB2340751B (en) 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
US6565873B1 (en) * 2000-10-25 2003-05-20 Salvona Llc Biodegradable bioadhesive controlled release system of nano-particles for oral care products
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
NZ531460A (en) 2001-10-19 2005-05-27 Idexx Lab Inc Controlled release - over at least 4-15 days - of injectable compositions comprising a lipophilic counterion such a saturated or unsaturated C10-C18 fatty acid
EP1567113A4 (fr) * 2002-10-24 2006-11-08 G & R Pharmaceuticals Llc Preparations antifongiques
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US20040197408A1 (en) * 2002-12-30 2004-10-07 Angiotech International Ag Amino acids in micelle preparation
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
MXPA05009978A (es) * 2003-03-20 2005-11-04 Pharmacia Corp Formulacion dispersable de un agente antiinflamatorio.
US20040204471A1 (en) * 2003-03-20 2004-10-14 Pharmacia Corporation Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents
US8003616B2 (en) * 2004-04-23 2011-08-23 Albert Rory J Composition for the treatment of ear infections and method
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same

Also Published As

Publication number Publication date
CN101014323B (zh) 2012-09-05
HUS1500004I1 (hu) 2017-09-28
CN101014323A (zh) 2007-08-08
US7854943B2 (en) 2010-12-21
US20050287198A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
IN2014DN08284A (fr)
JP2004283597A5 (fr)
JP2005013743A5 (fr)
JP2005292112A5 (fr)
IN2007DN02514A (fr)
JP2005204288A5 (fr)
JP2004361402A5 (fr)
JP2005102148A5 (fr)
JP2004256553A5 (fr)
IN244537B (fr)
JP2004320981A5 (fr)
JP2005036199A5 (fr)
JP2005161053A5 (fr)
JP2004228090A5 (fr)
JP2005259891A5 (fr)
JP2005284367A5 (fr)
JP2005216448A5 (fr)
JP2005261768A5 (fr)
JP2005258579A5 (fr)
JP2005281922A5 (fr)
JP2005245479A5 (fr)
JP2005228997A5 (fr)
JP2005054796A5 (fr)
JP2005000178A5 (fr)
JP2005194171A5 (fr)